Erectile Dysfunction Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Erectile Dysfunction Market is expected to retract at a CAGR of around 2% during the period 2022−2028.

Erectile dysfunction (ED) is primarily characterized by persistent problems with achieving and maintaining an erection adequate for sexual intercourse. The erectile dysfunction drug market is driven by the following components: an increasing number of men suffering from this problem, a growing geriatric population, and patent expiry of a number of blockbuster drugs. Furthermore, the expansion of manufacturing of non-proprietary drugs coupled with an increase in fixed lifestyles along with the associated pressures is expected to significantly propel the market development.

Market Segments

By Products

• Drugs
• Devices

By Devices

• Penile Implants
• Vacuum Therapy Devices
• Shockwave Therapy
• Others

Key Players

• Eli Lilly and Company
• VIVUS
• Pfizer
• Bayer
• Boston Scientific
• Coloplast
• Teva Pharmaceuticals
• Viatris

Scope of the Report

The research study analyzes the global Erectile Dysfunction industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Erectile Dysfunction Market Report

1. What was the Erectile Dysfunction Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Erectile Dysfunction Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Erectile Dysfunction Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.